Latest news
Definium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss - simplywall.stsimplywall.st · Sat, 08 Aug 2026 23:35:37 GMTDefinium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 21:28:36 GMTStrong Positive Phase Eastern Atlantic/Western Russia (EAWR) Index Dominates North America/Europe Medium-range Outlook - Climate Impact CompanyClimate Impact Company · Fri, 07 Aug 2026 11:06:33 GMTRelmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 05:09:29 GMTRLMD: Strong cash position and robust NDV-01 phase II results set stage for late-stage trials in 2026 - TradingViewTradingView · Thu, 06 Aug 2026 21:59:56 GMTNTLA: Strong Phase 3 data for lonvo-z and robust cash position support operations into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 20:09:49 GMTNTLA: Strong Phase 3 data and robust cash position set stage for lonvo-z launch and nex-z progress - TradingViewTradingView · Thu, 06 Aug 2026 11:09:30 GMTAVTX: Strong Phase 2 data and $405M equity raise position the company for pivotal Phase 3 advancement - TradingViewTradingView · Thu, 06 Aug 2026 11:05:13 GMT